Millennium Management’s Instil Bio TIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.1M Sell
132,946
-109,826
-45% -$891K ﹤0.01% 4318
2025
Q4
$2.67M Buy
242,772
+46,030
+23% +$681K ﹤0.01% 3686
2025
Q3
$3.51M Buy
196,742
+88,645
+82% +$2.25M ﹤0.01% 3498
2025
Q2
$2.25M Sell
108,097
-104,147
-49% -$2.18M ﹤0.01% 3779
2025
Q1
$3.68M Buy
212,244
+158,991
+299% +$3.3M ﹤0.01% 3166
2024
Q4
$1.02M Buy
+53,253
New +$1.62M ﹤0.01% 4189
2024
Q3
Sell
-31,631
Closed -$325K 6473
2024
Q2
$325K Buy
31,631
+250
+0.8% +$2.7K ﹤0.01% 4865
2024
Q1
$339K Sell
31,381
-18,356
-37% -$201K ﹤0.01% 5054
2023
Q4
$379K Sell
49,737
-39,379
-44% -$285K ﹤0.01% 4822
2023
Q3
$763K Sell
89,116
-2,116
-2% -$21.3K ﹤0.01% 4375
2023
Q2
$1.01M Buy
91,232
+26,373
+41% +$322K ﹤0.01% 4040
2023
Q1
$857K Buy
64,859
+25,725
+66% +$380K ﹤0.01% 4230
2022
Q4
$493K Buy
+39,134
New +$1.93M ﹤0.01% 4759
2021
Q2
Sell
-17,389
Closed -$8.72M 7102
2021
Q1
$8.72M Buy
+17,389
New +$8.92M 0.01% 1935

Other funds holding TIL

Millennium Management's TIL Position: Q1 2026 in Review

Millennium Management reduced its Instil Bio (TIL) stake by 45% in Q1 2026, selling an estimated $891K and leaving 132,946 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #4318.

Millennium Management first reported a position in TIL in Q1 2021 and has held it in 14 quarters since. The position peaked at $8.72M in Q1 2021. 32 funds tracked by Wall St. Rank hold TIL as of Q1 2026.

  • Millennium Management held 132,946 shares of Instil Bio worth $1.1M as of Q1 2026.
  • Millennium Management sold 109,826 Instil Bio shares in Q1 2026, an estimated $891K.
  • Instil Bio made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #4318 holding.
  • Millennium Management first reported a position in Instil Bio in Q1 2021 and has held it in 14 quarters since.
  • Millennium Management's Instil Bio position peaked at $8.72M in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Instil Bio as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.